Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Hoffmann-La Roche
RECORDATI GROUP
University of California, San Francisco
Merck Sharp & Dohme LLC